Can Keytruda (pembrolizumab) cause diarrhea?
Yes. Diarrhea is a known side effect of Keytruda. When it happens, doctors often treat it as possible immune-related inflammation of the colon (immune-mediated colitis), especially in patients who are also having abdominal pain or blood/mucus in stool.
Because the cause can range from common GI irritation to immune-mediated colitis, clinicians typically check severity and timing relative to treatment.
What side effects should patients watch for with Keytruda-related diarrhea?
Patients are generally advised to seek medical guidance if diarrhea is more than mild or does not improve. Extra warning signs include:
- Blood or mucus in stool
- Severe or worsening abdominal pain
- Fever
- Signs of dehydration (dizziness, reduced urination, extreme thirst)
- Diarrhea that continues or rapidly escalates after starting or increasing Keytruda
These features matter because they can suggest immune-mediated colitis, which may require prescription treatment and sometimes holding Keytruda.
How do doctors decide whether diarrhea is immune-mediated colitis?
Clinicians usually base the decision on several practical factors:
- Severity (how many times per day, and whether it interferes with daily life)
- Timing (whether it starts after beginning Keytruda and progresses)
- Presence of red-flag symptoms (blood, severe pain)
- Excluding other causes (infection, medication-related GI effects, bowel obstruction, etc.)
- Stool tests and, if needed, imaging or colon evaluation depending on severity
The key point is that Keytruda can trigger the immune system to inflame the GI tract, but diarrhea can also come from non-cancer causes.
What treatment is used for Keytruda diarrhea?
Treatment depends on severity and suspected cause. In immune-related GI toxicity, a typical approach is:
- Supportive care (hydration, anti-diarrheal strategies when appropriate, diet adjustments)
- Stopping or delaying Keytruda for moderate to severe symptoms
- Using anti-inflammatory treatment such as corticosteroids when immune-mediated colitis is suspected
Your oncology team will choose the plan based on how severe the diarrhea is and whether there are concerning symptoms.
When should Keytruda be held or dose delayed for diarrhea?
Clinicians often use severity-based rules (commonly graded in oncology, e.g., mild vs. moderate/severe). As diarrhea gets more frequent, lasts longer, or comes with blood/pain, the likelihood increases that Keytruda will be held and immune-directed treatment started. If the diarrhea is mild and improves quickly, some patients may be managed with supportive measures alone under close monitoring.
Only the treating team can apply the right threshold for an individual patient’s situation.
Are there at-home steps patients can take right now?
Patients should focus on safety and communication:
- Stay hydrated (oral fluids; ask your team what to drink and how much)
- Track stool frequency and any blood/mucus
- Avoid new over-the-counter medicines without checking with your oncology team, especially anti-diarrheals, because the right choice depends on suspected immune colitis vs. infection risk
- Contact the prescriber promptly if symptoms are more than mild or worsening
Could diarrhea be caused by something else besides Keytruda?
Yes. Common alternative causes include infections, antibiotics, food-related GI upset, other medications, and underlying bowel conditions. That is why clinicians assess for severity and may test for infectious causes when appropriate—particularly if symptoms are severe, persistent, or associated with fever.
How does Keytruda diarrhea affect ongoing treatment and prognosis?
The main practical impact is on treatment continuity and safety. Many patients who develop immune-related diarrhea can be managed so that cancer therapy continues when symptoms resolve and the toxicity is brought under control. The most important factors are early recognition, correct severity grading, and timely treatment of immune-mediated colitis if present.
Sources
- Drug information on immune-related adverse events, including diarrhea/colitis: https://www.drugs.com/ (search within for “pembrolizumab diarrhea” or “Keytruda immune-mediated colitis”)
- Drug safety information via prescribing resources is also typically updated in the official Keytruda label (check the most current label from the manufacturer or FDA).